Peer-reviewedLicence not statedFuture Medicinal Chemistry
Chalcone-pyridine/pyrimidine hybrids: promising candidates for anticancer drug development
- 1School of Chemistry and Pharmaceutical Engineering, Huanghuai University, Zhumadian, China
- 2Zhumadian Central Hospital, Zhumadian, China
Related
- Diiron(I) Complexes with Promising Anticancer Properties Obtained by CO-To-Isocyanide Substitution of [Fe2Cp2(CO)4]
- Systematic DFT Screening of Anti-Perovskite Nitrides for Chemical-Looping Ammonia Synthesis: Ca-Based Compounds as Promising Candidates
- Development of Novel Furan–Chalcone Derivatives as Targeting Bacterial DNA Gyrase and Topoisomerase IV: Design, Synthesis, and In Silico Studies
- Phytosynthesized Ag/MgO nanocomposite from Salvia rosmarinus: a promising multifunctional agent for anticancer, antibacterial, and metabolic enzyme inhibition
- Development of multifunctional chalcone–phthalonitrile–cyanate ester hybrids for thermal, flame-resistant, UV-protective, and dielectric applications
BibTeX
@article{wang2026chalconepyridinepyrimidine,
title = {{Chalcone-pyridine/pyrimidine hybrids: promising candidates for anticancer drug development}},
author = {Junjian Wang and Lumei Dai and Shifang Wen and Chuangjun Liu and Gaoli Dong},
journal = {Future Medicinal Chemistry},
year = {2026},
month = oct,
doi = {10.1080/17568919.2026.2741225},
url = {https://doi.org/10.1080/17568919.2026.2741225},
}
RIS
TY - JOUR
TI - Chalcone-pyridine/pyrimidine hybrids: promising candidates for anticancer drug development
AU - Junjian Wang
AU - Lumei Dai
AU - Shifang Wen
AU - Chuangjun Liu
AU - Gaoli Dong
PY - 2026
DA - 2026/10/01
JO - Future Medicinal Chemistry
DO - 10.1080/17568919.2026.2741225
UR - https://doi.org/10.1080/17568919.2026.2741225
SN - 1756-8919
SN - 1756-8927
ER -